{"id":15896,"date":"2024-03-10T15:14:32","date_gmt":"2024-03-10T07:14:32","guid":{"rendered":"http:\/\/cxounion.cn\/?p=15896"},"modified":"2024-03-10T15:14:35","modified_gmt":"2024-03-10T07:14:35","slug":"%e3%80%90%e8%a7%82%e7%82%b9%e3%80%91%e9%bd%90%e9%b2%81%e5%88%b6%e8%8d%af%e6%80%bb%e8%a3%81%e6%9d%8e%e7%87%95%ef%bc%9a%e6%94%af%e6%8c%81%e6%b0%91%e6%97%8f%e5%8c%bb%e8%8d%af%e4%ba%a7%e4%b8%9a%e5%88%9b","status":"publish","type":"post","link":"http:\/\/cxounion.cn\/index.php\/2024\/03\/10\/%e3%80%90%e8%a7%82%e7%82%b9%e3%80%91%e9%bd%90%e9%b2%81%e5%88%b6%e8%8d%af%e6%80%bb%e8%a3%81%e6%9d%8e%e7%87%95%ef%bc%9a%e6%94%af%e6%8c%81%e6%b0%91%e6%97%8f%e5%8c%bb%e8%8d%af%e4%ba%a7%e4%b8%9a%e5%88%9b\/","title":{"rendered":"\u3010\u89c2\u70b9\u3011\u9f50\u9c81\u5236\u836f\u603b\u88c1\u674e\u71d5\uff1a\u652f\u6301\u6c11\u65cf\u533b\u836f\u4ea7\u4e1a\u521b\u65b0\u5347\u7ea7"},"content":{"rendered":"\n

\u9f50\u9c81\u5236\u836f\u603b\u88c1\u674e\u71d5<\/figcaption><\/figure>\n\n\n\n
2024\u5e74\u5168\u56fd\u4e24\u4f1a\u53ec\u5f00\u671f\u95f4\uff0c\u7b2c\u5341\u56db\u5c4a\u5168\u56fd\u4eba\u5927\u4ee3\u8868\u3001\u9f50\u9c81\u5236\u836f\u603b\u88c1\u674e\u71d5\u51c6\u5907\u4e86\u591a\u4efd\u5efa\u8bae\u3002\u5176\u4e2d\uff0c\u5728\u300a\u5173\u4e8e\u652f\u6301\u6c11\u65cf\u533b\u836f\u4ea7\u4e1a\u521b\u65b0\u5347\u7ea7\u53d1\u5c55\u7684\u5efa\u8bae\u300b\u4e2d\uff0c\u5979\u5efa\u8bae\u575a\u6301\u7cfb\u7edf\u7406\u5ff5\uff0c\u6301\u7eed\u4f18\u5316\u836f\u7269\u7814\u53d1\u73af\u5883\uff1b\u652f\u6301\u4f01\u4e1a\u589e\u5f3a\u6838\u5fc3\u7ade\u4e89\u529b\uff0c\u5207\u5b9e\u5960\u5b9a\u6c11\u65cf\u533b\u836f\u4ea7\u4e1a\u53d1\u5c55\u6839\u57fa\uff1b\u6784\u5efa\u534f\u540c\u521b\u65b0\u8f6c\u5316\u673a\u5236\uff0c\u63d0\u9ad8\u79d1\u7814\u6210\u679c\u8f6c\u5316\u6548\u7387\uff1b\u8fdb\u4e00\u6b65\u5b8c\u5584\u5e02\u573a\u51c6\u5165\u7b49\u653f\u7b56\uff0c\u4fdd\u969c\u53d1\u5c55\u53ef\u6301\u7eed\u3002<\/p>\n\n\n\n
\u674e\u71d5\u8ba4\u4e3a\uff0c\u5f53\u524d\u6211\u56fd\u533b\u836f\u4ea7\u4e1a\u53d1\u5c55\u8fdb\u5165\u65b0\u9636\u6bb5\uff0c\u533b\u836f\u536b\u751f\u4f53\u5236\u6539\u9769\u6df1\u5165\u63a8\u8fdb\uff0c\u83b7\u6279\u65b0\u836f\u6570\u91cf\u5c61\u521b\u65b0\u9ad8\u3002\u4f46\u4e2d\u56fd\u533b\u836f\u4ea7\u4e1a\u53d1\u5c55\u662f\u4e00\u9879\u7cfb\u7edf\u5de5\u7a0b\uff0c\u884c\u4e1a\u201c\u5185\u5377\u201d\u3001\u521b\u65b0\u80fd\u529b\u4e0d\u8db3\u3001\u9ad8\u8d28\u91cf\u521b\u65b0\u6210\u679c\u5c11\u3001\u6574\u4f53\u56fd\u9645\u7ade\u4e89\u529b\u504f\u5f31\u7b49\u95ee\u9898\u4f9d\u7136\u5b58\u5728\u3002\u9700\u8981\u5728\u73b0\u6709\u57fa\u7840\u4e0a\uff0c\u901a\u8fc7\u653f\u7b56\u7684\u7cfb\u7edf\u6027\u5efa\u6784\u3001\u4f53\u7cfb\u6027\u6574\u5851\uff0c\u8fdb\u4e00\u6b65\u53d1\u6325\u597d\u653f\u7b56\u7684\u96c6\u4e2d\u7ec4\u5408\u6548\u5e94\uff0c\u5145\u5206\u91ca\u653e\u6c11\u65cf\u533b\u836f\u4ea7\u4e1a\u548c\u4f01\u4e1a\u53d1\u5c55\u65b0\u6d3b\u529b\u3002<\/p>\n\n\n\n
\u201c\u5728\u8fdb\u884c\u56fd\u5bb6\u836f\u54c1\u76d1\u7ba1\u5236\u5ea6\u9876\u5c42\u8bbe\u8ba1\u65f6\uff0c\u65e2\u8981\u4fdd\u8bc1\u76d1\u7ba1\u7684\u79d1\u5b66\u6027\uff0c\u4e5f\u8981\u7edf\u7b79\u6c11\u4f17\u5229\u76ca\u3001\u4ea7\u4e1a\u53d1\u5c55\u3002\u65e2\u9f13\u52b1\u521b\u65b0\uff0c\u53c8\u6b63\u89c6\u6211\u56fd\u5236\u836f\u4ea7\u4e1a\u53d1\u5c55\u9636\u6bb5\u548c\u5b9e\u9645\uff0c\u5728\u89c4\u907f\u4f4e\u6c34\u5e73\u521b\u65b0\u5bfc\u81f4\u7684\u2018\u5185\u5377\u2019\u548c\u7ed9\u4f4e\u6c34\u5e73\u521b\u65b0\u4ea7\u54c1\u2018\u4fdd\u62a4\u2019\u7684\u540c\u65f6\uff0c\u5bf9\u4f01\u4e1a\u521b\u65b0\u4e2d\u9047\u5230\u7684\u95ee\u9898\u7ed9\u4e88\u6307\u5bfc\u548c\u652f\u6301\u3002\u201d\u674e\u71d5\u8bf4\u3002 CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
\u4e3a\u6b64\uff0c\u5979\u5efa\u8bae\u56fd\u5bb6\u6709\u5173\u90e8\u95e8\u52a0\u5f3a\u653f\u7b56\u4f1a\u5546\u548c\u90e8\u9645\u8054\u52a8\uff0c\u7efc\u5408\u6027\u653f\u7b56\u5171\u540c\u8c0b\u5212\uff0c\u4e13\u95e8\u6027\u653f\u7b56\u76f8\u4e92\u8854\u63a5\uff0c\u5bc6\u5207\u914d\u5408\u63a8\u8fdb\u533b\u836f\u536b\u751f\u4f53\u5236\u6539\u9769\uff0c\u52a0\u5f3a\u533b\u4fdd\u3001\u533b\u7597\u3001\u533b\u836f\u534f\u540c\u53d1\u5c55\u548c\u7efc\u5408\u6cbb\u7406\u3002<\/p>\n\n\n\n
\u201c\u6211\u56fd\u533b\u836f\u4ea7\u4e1a\u3001\u5934\u90e8\u533b\u836f\u4f01\u4e1a\u76ee\u524d\u5904\u4e8e\u2018\u4eff\u8f6c\u521b\u2019\u7684\u722c\u5761\u8fc7\u574e\u671f\uff0c\u9700\u8981\u52a0\u5927\u91ca\u653e\u653f\u7b56\u7ea2\u5229\uff0c\u4e0d\u65ad\u57f9\u80b2\u5de9\u56fa\u4f01\u4e1a\u521b\u65b0\u4e3b\u4f53\u5730\u4f4d\u3002\u201d\u674e\u71d5\u5efa\u8bae\u5728\u5168\u56fd\u91cd\u70b9\u5b9e\u9a8c\u5ba4\u7b49\u91cd\u5927\u56fd\u5bb6\u5e73\u53f0\u4e0a\uff0c\u7ed9\u4e88\u6c11\u8425\u533b\u836f\u9f99\u5934\u4f01\u4e1a\u5355\u72ec\u7533\u62a5\u901a\u9053\uff0c\u52a9\u529b\u4f01\u4e1a\u521b\u65b0\u53d1\u5c55\u3002\u5728\u79d1\u6280\u9879\u76ee\u7acb\u9879\u3001\u8bc4\u5ba1\u8fc7\u7a0b\u4e2d\u63d0\u5347\u4f01\u4e1a\u4e13\u5bb6\u6bd4\u4f8b\uff0c\u63d0\u5347\u4ea7\u4e1a\u5316\u5e94\u7528\u79d1\u6280\u521b\u65b0\u9879\u76ee\u6bd4\u4f8b\uff0c\u63a2\u7d22\u5efa\u7acb\u91cd\u70b9\u79d1\u6280\u578b\u4f01\u4e1a\u6210\u679c\u548c\u79d1\u7814\u9879\u76ee\u76f4\u62a5\u6e20\u9053\uff0c\u7ed9\u771f\u6b63\u5177\u6709\u521b\u65b0\u5b9e\u529b\u548c\u80fd\u529b\u7684\u4f01\u4e1a\u66f4\u591a\u201c\u9633\u5149\u96e8\u9732\u201d\u3002<\/p>\n\n\n\n
\u7ecf\u8fc7\u8c03\u67e5\u7814\u7a76\uff0c\u674e\u71d5\u53d1\u73b0\u521b\u65b0\u836f\u81ea\u8eab\u8fd8\u5b58\u5728\u4e0a\u5e02\u65f6\u95f4\u77ed\u3001\u6c11\u4f17\u8ba4\u77e5\u4e0d\u8db3\u3001\u4ef7\u683c\u76f8\u5bf9\u504f\u9ad8\u7b49\u4e0d\u8db3\uff0c\u4e34\u5e8a\u4f7f\u7528\u9762\u4e34\u201c\u5165\u9662\u96be\u201d\u201c\u5165\u533b\u4fdd\u96be\u201d\u53ca\u201c\u652f\u4ed8\u7ed3\u6784\u5355\u4e00\u201d\u7b49\u95ee\u9898\u3002<\/p>\n\n\n\n
\u5bf9\u6b64\uff0c\u5979\u5efa\u8bae\u533b\u4fdd\u90e8\u95e8\u89c4\u8303\u660e\u786e\u65b0\u4e0a\u5e02\u521b\u65b0\u836f\u7684\u8303\u56f4\u548c\u4ef7\u683c\u89c4\u5219\uff0c\u5f00\u901a\u5feb\u901f\u6302\u7f51\u901a\u9053\uff0c\u786e\u4fdd\u521b\u65b0\u836f\u4e0a\u5e02\u540e\u53ca\u65f6\u83b7\u5f97\u6302\u7f51\u51c6\u5165\u8d44\u8d28\u3002\u653e\u5bbd\u201c\u4e00\u54c1\u4e24\u89c4\u201d\u9650\u5236\uff0c\u901a\u8fc7\u5f00\u5c55\u836f\u54c1\u7efc\u5408\u8bc4\u4ef7\u6216\u836f\u54c1\u4ef7\u503c\u8bc4\u4f30\u7b49\u65b9\u5f0f\uff0c\u76d8\u6d3b\u65b0\u4e0a\u5e02\u3001\u9ad8\u54c1\u8d28\u836f\u54c1\u7684\u8fdb\u9662\u6e20\u9053\u3002\u52a0\u5f3a\u533b\u7597\u673a\u6784\u5bf9\u521b\u65b0\u836f\u5408\u7406\u914d\u5907\u4f7f\u7528\u7684\u91cd\u89c6\uff0c\u5fc5\u8981\u65f6\u901a\u8fc7\u884c\u653f\u624b\u6bb5\u5e72\u9884\uff0c\u8981\u6c42\u533b\u7597\u673a\u6784\u5b9a\u671f\u3001\u7cfb\u7edf\u5f00\u5c55\u65b0\u836f\u51c6\u5165\u5de5\u4f5c\uff0c\u4fdd\u8bc1\u521b\u65b0\u836f\u5e02\u573a\u51c6\u5165\u3002 CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
$\"\"\/$ <\/figure>\n\n\n\n
\u7ffb\u8bd1\uff1a<\/h2>\n\n\n\n
Li Yan, President of Qilu Pharmaceutical: Support the innovation and upgrading of the ethnic medicine industry<\/h3>\n\n\n\n
During the National Two Sessions in 2024, Li Yan, a deputy to the 14th National People’s Congress and president of Qilu Pharmaceutical, prepared a number of proposals. Among them, in the “Suggestions on Supporting the innovation and Upgrading of the Development of Ethnic Medicine Industry”, she suggested adhering to the system concept and continuously optimizing the drug research and development environment; Support enterprises to enhance their core competitiveness and lay a solid foundation for the development of ethnic medicine industry; Establish a collaborative innovation and transformation mechanism to improve the transformation efficiency of scientific research results; We will further improve market access and other policies to ensure sustainable development. CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
Li Yan believes that the current development of China’s pharmaceutical industry has entered a new stage, the reform of the medical and health system has been further promoted, and the number of approved new drugs has repeatedly reached a new high. However, the development of China’s pharmaceutical industry is a systematic project, and problems such as “internal volume”, insufficient innovation ability, few high-quality innovation achievements, and weak overall international competitiveness still exist. It is necessary to further exert the concentrated combination effect of policies through the systematic construction and systematic consolidation of policies on the existing basis, and fully release the new vitality of the development of ethnic medicine industry and enterprises.<\/p>\n\n\n\n
“In the top-level design of the national drug regulatory system, it is necessary to ensure the scientific nature of supervision, but also to coordinate the interests of the public and industrial development.” It not only encourages innovation, but also faces up to the development stage and reality of China’s pharmaceutical industry, and gives guidance and support to the problems encountered in the innovation of enterprises while avoiding the ‘internal volume’ caused by low-level innovation and ‘protection’ of low-level innovation products.” Li Yan said.<\/p>\n\n\n\n
To this end, she suggested that the relevant departments of the state strengthen policy consultation and inter-ministerial linkage, jointly plan comprehensive policies, connect specialized policies with each other, closely cooperate to promote the reform of the medical and health system, and strengthen the coordinated development and comprehensive management of medical insurance, medical treatment and medicine. CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
“China’s pharmaceutical industry and head pharmaceutical enterprises are currently in the climbing period of ‘imitation transformation’, and need to increase the release of policy dividends and constantly cultivate and consolidate the main position of enterprise innovation.” Li Yan suggested that on major national platforms such as national key laboratories, private pharmaceutical leading enterprises should be given a separate declaration channel to help enterprises innovate and develop. In the process of science and technology project establishment and evaluation, increase the proportion of enterprise experts, increase the proportion of industrial application science and technology innovation projects, explore the establishment of key science and technology enterprises and scientific research projects direct reporting channels, and give more “sunshine and rain” to enterprises with real innovation strength and ability.<\/p>\n\n\n\n
After investigation and research, Li Yan found that innovative drugs themselves still have shortcomings such as short listing time, lack of public awareness, relatively high price, and clinical use faces problems such as “difficult admission”, “difficult admission to medical insurance” and “single payment structure”.<\/p>\n\n\n\n
In this regard, she suggested that the medical insurance department regulate and clarify the scope and price rules of the newly listed innovative drugs, open the fast hook network channel, and ensure that the innovative drugs get the hook network access qualification in time after the listing. Relax the restrictions of “one product and two regulations”, and activate the channels for newly listed and high-quality drugs to enter the hospital by carrying out comprehensive drug evaluation or drug value evaluation. Strengthen the attention of medical institutions to the rational allocation and use of innovative drugs, intervene through administrative means when necessary, and require medical institutions to regularly and systematically carry out new drug access work to ensure market access for innovative drugs. CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
\u7531CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/a>\u8f6c\u8f7d\u800c\u6210\uff0c\u6765\u6e90\u4e8e\u4e2d\u4e2d\u534e\u5de5\u5546\u65f6\u62a5\uff1b\u7f16\u8f91\/\u7ffb\u8bd1\uff1aCXO UNIONCXO\u8054\u76df\u5c0fU\u3002<\/p>\n\n\n\n
\u5982\u9700\u52a0\u5165 CXO UNION\uff08CXO\u8054\u76df\uff09<\/a>\u9ad8\u7ba1\u793e\u7fa4\uff0c\u8bf7\u8054\u7cfb\u793e\u7fa4\u5c0f\u4f19\u4f34\u54e6~<\/p>\n\n\n\n
$\"\"\/$ <\/figure>\n\n\n\n
\u514d\u8d23\u58f0\u660e: \u672c\u7f51\u7ad9(http:\/\/www.cxounion.cn\/<\/a>)\u5185\u5bb9\u4e3b\u8981\u6765\u81ea\u539f\u521b\u3001\u5408\u4f5c\u5a92\u4f53\u4f9b\u7a3f\u548c\u7b2c\u4e09\u65b9\u6295\u7a3f\uff0c\u51e1\u5728\u672c\u7f51\u7ad9\u51fa\u73b0\u7684\u4fe1\u606f\uff0c\u5747\u4ec5\u4f9b\u53c2\u8003\u3002\u672c\u7f51\u7ad9\u5c06\u5c3d\u529b\u786e\u4fdd\u6240\u63d0\u4f9b\u4fe1\u606f\u7684\u51c6\u786e\u6027\u53ca\u53ef\u9760\u6027\uff0c\u4f46\u4e0d\u4fdd\u8bc1\u6709\u5173\u8d44\u6599\u7684\u51c6\u786e\u6027\u53ca\u53ef\u9760\u6027\uff0c\u8bfb\u8005\u5728\u4f7f\u7528\u524d\u8bf7\u8fdb\u4e00\u6b65\u6838\u5b9e\uff0c\u5e76\u5bf9\u4efb\u4f55\u81ea\u4e3b\u51b3\u5b9a\u7684\u884c\u4e3a\u8d1f\u8d23\u3002\u672c\u7f51\u7ad9\u5bf9\u6709\u5173\u8d44\u6599\u6240\u5f15\u81f4\u7684\u9519\u8bef\u3001\u4e0d\u786e\u6216\u9057\u6f0f\uff0c\u6982\u4e0d\u8d1f\u4efb\u4f55\u6cd5\u5f8b\u8d23\u4efb\u3002<\/p>\n\n\n\n
\u672c\u7f51\u7ad9\u520a\u8f7d\u7684\u6240\u6709\u5185\u5bb9(\u5305\u62ec\u4f46\u4e0d\u4ec5\u9650\u6587\u5b57\u3001\u56fe\u7247\u3001LOGO\u3001\u97f3\u9891\u3001\u89c6\u9891\u3001\u8f6f\u4ef6\u3001\u7a0b\u5e8f\u7b49) \u7248\u6743\u5f52\u539f\u4f5c\u8005\u6240\u6709\u3002\u4efb\u4f55\u5355\u4f4d\u6216\u4e2a\u4eba\u8ba4\u4e3a\u672c\u7f51\u7ad9\u4e2d\u7684\u5185\u5bb9\u53ef\u80fd\u6d89\u5acc\u4fb5\u72af\u5176\u77e5\u8bc6\u4ea7\u6743\u6216\u5b58\u5728\u4e0d\u5b9e\u5185\u5bb9\u65f6\uff0c\u8bf7\u53ca\u65f6\u901a\u77e5\u672c\u7ad9\uff0c\u4e88\u4ee5\u5220\u9664\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
2024\u5e74\u5168\u56fd\u4e24\u4f1a\u53ec\u5f00\u671f\u95f4\uff0c\u7b2c\u5341\u56db\u5c4a\u5168\u56fd\u4eba\u5927\u4ee3\u8868\u3001\u9f50\u9c81\u5236\u836f\u603b\u88c1\u674e\u71d5\u51c6\u5907\u4e86\u591a\u4efd\u5efa\u8bae\u3002<\/p>\n","protected":false},"author":1,"featured_media":15898,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,31,13],"tags":[503],"class_list":["post-15896","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ceo","category-cxo","category-viewpoint","tag-503"],"_links":{"self":[{"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/posts\/15896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/comments?post=15896"}],"version-history":[{"count":1,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/posts\/15896\/revisions"}],"predecessor-version":[{"id":15902,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/posts\/15896\/revisions\/15902"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/media\/15898"}],"wp:attachment":[{"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/media?parent=15896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/categories?post=15896"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/tags?post=15896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

\u9f50\u9c81\u5236\u836f\u603b\u88c1\u674e\u71d5<\/figcaption><\/figure>\n\n\n\n
2024\u5e74\u5168\u56fd\u4e24\u4f1a\u53ec\u5f00\u671f\u95f4\uff0c\u7b2c\u5341\u56db\u5c4a\u5168\u56fd\u4eba\u5927\u4ee3\u8868\u3001\u9f50\u9c81\u5236\u836f\u603b\u88c1\u674e\u71d5\u51c6\u5907\u4e86\u591a\u4efd\u5efa\u8bae\u3002\u5176\u4e2d\uff0c\u5728\u300a\u5173\u4e8e\u652f\u6301\u6c11\u65cf\u533b\u836f\u4ea7\u4e1a\u521b\u65b0\u5347\u7ea7\u53d1\u5c55\u7684\u5efa\u8bae\u300b\u4e2d\uff0c\u5979\u5efa\u8bae\u575a\u6301\u7cfb\u7edf\u7406\u5ff5\uff0c\u6301\u7eed\u4f18\u5316\u836f\u7269\u7814\u53d1\u73af\u5883\uff1b\u652f\u6301\u4f01\u4e1a\u589e\u5f3a\u6838\u5fc3\u7ade\u4e89\u529b\uff0c\u5207\u5b9e\u5960\u5b9a\u6c11\u65cf\u533b\u836f\u4ea7\u4e1a\u53d1\u5c55\u6839\u57fa\uff1b\u6784\u5efa\u534f\u540c\u521b\u65b0\u8f6c\u5316\u673a\u5236\uff0c\u63d0\u9ad8\u79d1\u7814\u6210\u679c\u8f6c\u5316\u6548\u7387\uff1b\u8fdb\u4e00\u6b65\u5b8c\u5584\u5e02\u573a\u51c6\u5165\u7b49\u653f\u7b56\uff0c\u4fdd\u969c\u53d1\u5c55\u53ef\u6301\u7eed\u3002<\/p>\n\n\n\n
\u674e\u71d5\u8ba4\u4e3a\uff0c\u5f53\u524d\u6211\u56fd\u533b\u836f\u4ea7\u4e1a\u53d1\u5c55\u8fdb\u5165\u65b0\u9636\u6bb5\uff0c\u533b\u836f\u536b\u751f\u4f53\u5236\u6539\u9769\u6df1\u5165\u63a8\u8fdb\uff0c\u83b7\u6279\u65b0\u836f\u6570\u91cf\u5c61\u521b\u65b0\u9ad8\u3002\u4f46\u4e2d\u56fd\u533b\u836f\u4ea7\u4e1a\u53d1\u5c55\u662f\u4e00\u9879\u7cfb\u7edf\u5de5\u7a0b\uff0c\u884c\u4e1a\u201c\u5185\u5377\u201d\u3001\u521b\u65b0\u80fd\u529b\u4e0d\u8db3\u3001\u9ad8\u8d28\u91cf\u521b\u65b0\u6210\u679c\u5c11\u3001\u6574\u4f53\u56fd\u9645\u7ade\u4e89\u529b\u504f\u5f31\u7b49\u95ee\u9898\u4f9d\u7136\u5b58\u5728\u3002\u9700\u8981\u5728\u73b0\u6709\u57fa\u7840\u4e0a\uff0c\u901a\u8fc7\u653f\u7b56\u7684\u7cfb\u7edf\u6027\u5efa\u6784\u3001\u4f53\u7cfb\u6027\u6574\u5851\uff0c\u8fdb\u4e00\u6b65\u53d1\u6325\u597d\u653f\u7b56\u7684\u96c6\u4e2d\u7ec4\u5408\u6548\u5e94\uff0c\u5145\u5206\u91ca\u653e\u6c11\u65cf\u533b\u836f\u4ea7\u4e1a\u548c\u4f01\u4e1a\u53d1\u5c55\u65b0\u6d3b\u529b\u3002<\/p>\n\n\n\n
\u201c\u5728\u8fdb\u884c\u56fd\u5bb6\u836f\u54c1\u76d1\u7ba1\u5236\u5ea6\u9876\u5c42\u8bbe\u8ba1\u65f6\uff0c\u65e2\u8981\u4fdd\u8bc1\u76d1\u7ba1\u7684\u79d1\u5b66\u6027\uff0c\u4e5f\u8981\u7edf\u7b79\u6c11\u4f17\u5229\u76ca\u3001\u4ea7\u4e1a\u53d1\u5c55\u3002\u65e2\u9f13\u52b1\u521b\u65b0\uff0c\u53c8\u6b63\u89c6\u6211\u56fd\u5236\u836f\u4ea7\u4e1a\u53d1\u5c55\u9636\u6bb5\u548c\u5b9e\u9645\uff0c\u5728\u89c4\u907f\u4f4e\u6c34\u5e73\u521b\u65b0\u5bfc\u81f4\u7684\u2018\u5185\u5377\u2019\u548c\u7ed9\u4f4e\u6c34\u5e73\u521b\u65b0\u4ea7\u54c1\u2018\u4fdd\u62a4\u2019\u7684\u540c\u65f6\uff0c\u5bf9\u4f01\u4e1a\u521b\u65b0\u4e2d\u9047\u5230\u7684\u95ee\u9898\u7ed9\u4e88\u6307\u5bfc\u548c\u652f\u6301\u3002\u201d\u674e\u71d5\u8bf4\u3002 CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
\u4e3a\u6b64\uff0c\u5979\u5efa\u8bae\u56fd\u5bb6\u6709\u5173\u90e8\u95e8\u52a0\u5f3a\u653f\u7b56\u4f1a\u5546\u548c\u90e8\u9645\u8054\u52a8\uff0c\u7efc\u5408\u6027\u653f\u7b56\u5171\u540c\u8c0b\u5212\uff0c\u4e13\u95e8\u6027\u653f\u7b56\u76f8\u4e92\u8854\u63a5\uff0c\u5bc6\u5207\u914d\u5408\u63a8\u8fdb\u533b\u836f\u536b\u751f\u4f53\u5236\u6539\u9769\uff0c\u52a0\u5f3a\u533b\u4fdd\u3001\u533b\u7597\u3001\u533b\u836f\u534f\u540c\u53d1\u5c55\u548c\u7efc\u5408\u6cbb\u7406\u3002<\/p>\n\n\n\n
\u201c\u6211\u56fd\u533b\u836f\u4ea7\u4e1a\u3001\u5934\u90e8\u533b\u836f\u4f01\u4e1a\u76ee\u524d\u5904\u4e8e\u2018\u4eff\u8f6c\u521b\u2019\u7684\u722c\u5761\u8fc7\u574e\u671f\uff0c\u9700\u8981\u52a0\u5927\u91ca\u653e\u653f\u7b56\u7ea2\u5229\uff0c\u4e0d\u65ad\u57f9\u80b2\u5de9\u56fa\u4f01\u4e1a\u521b\u65b0\u4e3b\u4f53\u5730\u4f4d\u3002\u201d\u674e\u71d5\u5efa\u8bae\u5728\u5168\u56fd\u91cd\u70b9\u5b9e\u9a8c\u5ba4\u7b49\u91cd\u5927\u56fd\u5bb6\u5e73\u53f0\u4e0a\uff0c\u7ed9\u4e88\u6c11\u8425\u533b\u836f\u9f99\u5934\u4f01\u4e1a\u5355\u72ec\u7533\u62a5\u901a\u9053\uff0c\u52a9\u529b\u4f01\u4e1a\u521b\u65b0\u53d1\u5c55\u3002\u5728\u79d1\u6280\u9879\u76ee\u7acb\u9879\u3001\u8bc4\u5ba1\u8fc7\u7a0b\u4e2d\u63d0\u5347\u4f01\u4e1a\u4e13\u5bb6\u6bd4\u4f8b\uff0c\u63d0\u5347\u4ea7\u4e1a\u5316\u5e94\u7528\u79d1\u6280\u521b\u65b0\u9879\u76ee\u6bd4\u4f8b\uff0c\u63a2\u7d22\u5efa\u7acb\u91cd\u70b9\u79d1\u6280\u578b\u4f01\u4e1a\u6210\u679c\u548c\u79d1\u7814\u9879\u76ee\u76f4\u62a5\u6e20\u9053\uff0c\u7ed9\u771f\u6b63\u5177\u6709\u521b\u65b0\u5b9e\u529b\u548c\u80fd\u529b\u7684\u4f01\u4e1a\u66f4\u591a\u201c\u9633\u5149\u96e8\u9732\u201d\u3002<\/p>\n\n\n\n
\u7ecf\u8fc7\u8c03\u67e5\u7814\u7a76\uff0c\u674e\u71d5\u53d1\u73b0\u521b\u65b0\u836f\u81ea\u8eab\u8fd8\u5b58\u5728\u4e0a\u5e02\u65f6\u95f4\u77ed\u3001\u6c11\u4f17\u8ba4\u77e5\u4e0d\u8db3\u3001\u4ef7\u683c\u76f8\u5bf9\u504f\u9ad8\u7b49\u4e0d\u8db3\uff0c\u4e34\u5e8a\u4f7f\u7528\u9762\u4e34\u201c\u5165\u9662\u96be\u201d\u201c\u5165\u533b\u4fdd\u96be\u201d\u53ca\u201c\u652f\u4ed8\u7ed3\u6784\u5355\u4e00\u201d\u7b49\u95ee\u9898\u3002<\/p>\n\n\n\n
\u5bf9\u6b64\uff0c\u5979\u5efa\u8bae\u533b\u4fdd\u90e8\u95e8\u89c4\u8303\u660e\u786e\u65b0\u4e0a\u5e02\u521b\u65b0\u836f\u7684\u8303\u56f4\u548c\u4ef7\u683c\u89c4\u5219\uff0c\u5f00\u901a\u5feb\u901f\u6302\u7f51\u901a\u9053\uff0c\u786e\u4fdd\u521b\u65b0\u836f\u4e0a\u5e02\u540e\u53ca\u65f6\u83b7\u5f97\u6302\u7f51\u51c6\u5165\u8d44\u8d28\u3002\u653e\u5bbd\u201c\u4e00\u54c1\u4e24\u89c4\u201d\u9650\u5236\uff0c\u901a\u8fc7\u5f00\u5c55\u836f\u54c1\u7efc\u5408\u8bc4\u4ef7\u6216\u836f\u54c1\u4ef7\u503c\u8bc4\u4f30\u7b49\u65b9\u5f0f\uff0c\u76d8\u6d3b\u65b0\u4e0a\u5e02\u3001\u9ad8\u54c1\u8d28\u836f\u54c1\u7684\u8fdb\u9662\u6e20\u9053\u3002\u52a0\u5f3a\u533b\u7597\u673a\u6784\u5bf9\u521b\u65b0\u836f\u5408\u7406\u914d\u5907\u4f7f\u7528\u7684\u91cd\u89c6\uff0c\u5fc5\u8981\u65f6\u901a\u8fc7\u884c\u653f\u624b\u6bb5\u5e72\u9884\uff0c\u8981\u6c42\u533b\u7597\u673a\u6784\u5b9a\u671f\u3001\u7cfb\u7edf\u5f00\u5c55\u65b0\u836f\u51c6\u5165\u5de5\u4f5c\uff0c\u4fdd\u8bc1\u521b\u65b0\u836f\u5e02\u573a\u51c6\u5165\u3002 CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
$\"\"\/$ <\/figure>\n\n\n\n
\u7ffb\u8bd1\uff1a<\/h2>\n\n\n\n
Li Yan, President of Qilu Pharmaceutical: Support the innovation and upgrading of the ethnic medicine industry<\/h3>\n\n\n\n
During the National Two Sessions in 2024, Li Yan, a deputy to the 14th National People’s Congress and president of Qilu Pharmaceutical, prepared a number of proposals. Among them, in the “Suggestions on Supporting the innovation and Upgrading of the Development of Ethnic Medicine Industry”, she suggested adhering to the system concept and continuously optimizing the drug research and development environment; Support enterprises to enhance their core competitiveness and lay a solid foundation for the development of ethnic medicine industry; Establish a collaborative innovation and transformation mechanism to improve the transformation efficiency of scientific research results; We will further improve market access and other policies to ensure sustainable development. CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
Li Yan believes that the current development of China’s pharmaceutical industry has entered a new stage, the reform of the medical and health system has been further promoted, and the number of approved new drugs has repeatedly reached a new high. However, the development of China’s pharmaceutical industry is a systematic project, and problems such as “internal volume”, insufficient innovation ability, few high-quality innovation achievements, and weak overall international competitiveness still exist. It is necessary to further exert the concentrated combination effect of policies through the systematic construction and systematic consolidation of policies on the existing basis, and fully release the new vitality of the development of ethnic medicine industry and enterprises.<\/p>\n\n\n\n
“In the top-level design of the national drug regulatory system, it is necessary to ensure the scientific nature of supervision, but also to coordinate the interests of the public and industrial development.” It not only encourages innovation, but also faces up to the development stage and reality of China’s pharmaceutical industry, and gives guidance and support to the problems encountered in the innovation of enterprises while avoiding the ‘internal volume’ caused by low-level innovation and ‘protection’ of low-level innovation products.” Li Yan said.<\/p>\n\n\n\n
To this end, she suggested that the relevant departments of the state strengthen policy consultation and inter-ministerial linkage, jointly plan comprehensive policies, connect specialized policies with each other, closely cooperate to promote the reform of the medical and health system, and strengthen the coordinated development and comprehensive management of medical insurance, medical treatment and medicine. CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
“China’s pharmaceutical industry and head pharmaceutical enterprises are currently in the climbing period of ‘imitation transformation’, and need to increase the release of policy dividends and constantly cultivate and consolidate the main position of enterprise innovation.” Li Yan suggested that on major national platforms such as national key laboratories, private pharmaceutical leading enterprises should be given a separate declaration channel to help enterprises innovate and develop. In the process of science and technology project establishment and evaluation, increase the proportion of enterprise experts, increase the proportion of industrial application science and technology innovation projects, explore the establishment of key science and technology enterprises and scientific research projects direct reporting channels, and give more “sunshine and rain” to enterprises with real innovation strength and ability.<\/p>\n\n\n\n
After investigation and research, Li Yan found that innovative drugs themselves still have shortcomings such as short listing time, lack of public awareness, relatively high price, and clinical use faces problems such as “difficult admission”, “difficult admission to medical insurance” and “single payment structure”.<\/p>\n\n\n\n
In this regard, she suggested that the medical insurance department regulate and clarify the scope and price rules of the newly listed innovative drugs, open the fast hook network channel, and ensure that the innovative drugs get the hook network access qualification in time after the listing. Relax the restrictions of “one product and two regulations”, and activate the channels for newly listed and high-quality drugs to enter the hospital by carrying out comprehensive drug evaluation or drug value evaluation. Strengthen the attention of medical institutions to the rational allocation and use of innovative drugs, intervene through administrative means when necessary, and require medical institutions to regularly and systematically carry out new drug access work to ensure market access for innovative drugs. CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/mark><\/p>\n\n\n\n
\u7531CXO UNION-CXO\u8054\u76df\uff08cxounion.cn\uff09<\/a>\u8f6c\u8f7d\u800c\u6210\uff0c\u6765\u6e90\u4e8e\u4e2d\u4e2d\u534e\u5de5\u5546\u65f6\u62a5\uff1b\u7f16\u8f91\/\u7ffb\u8bd1\uff1aCXO UNIONCXO\u8054\u76df\u5c0fU\u3002<\/p>\n\n\n\n
\u5982\u9700\u52a0\u5165 CXO UNION\uff08CXO\u8054\u76df\uff09<\/a>\u9ad8\u7ba1\u793e\u7fa4\uff0c\u8bf7\u8054\u7cfb\u793e\u7fa4\u5c0f\u4f19\u4f34\u54e6~<\/p>\n\n\n\n
$\"\"\/$ <\/figure>\n\n\n\n
\u514d\u8d23\u58f0\u660e: \u672c\u7f51\u7ad9(http:\/\/www.cxounion.cn\/<\/a>)\u5185\u5bb9\u4e3b\u8981\u6765\u81ea\u539f\u521b\u3001\u5408\u4f5c\u5a92\u4f53\u4f9b\u7a3f\u548c\u7b2c\u4e09\u65b9\u6295\u7a3f\uff0c\u51e1\u5728\u672c\u7f51\u7ad9\u51fa\u73b0\u7684\u4fe1\u606f\uff0c\u5747\u4ec5\u4f9b\u53c2\u8003\u3002\u672c\u7f51\u7ad9\u5c06\u5c3d\u529b\u786e\u4fdd\u6240\u63d0\u4f9b\u4fe1\u606f\u7684\u51c6\u786e\u6027\u53ca\u53ef\u9760\u6027\uff0c\u4f46\u4e0d\u4fdd\u8bc1\u6709\u5173\u8d44\u6599\u7684\u51c6\u786e\u6027\u53ca\u53ef\u9760\u6027\uff0c\u8bfb\u8005\u5728\u4f7f\u7528\u524d\u8bf7\u8fdb\u4e00\u6b65\u6838\u5b9e\uff0c\u5e76\u5bf9\u4efb\u4f55\u81ea\u4e3b\u51b3\u5b9a\u7684\u884c\u4e3a\u8d1f\u8d23\u3002\u672c\u7f51\u7ad9\u5bf9\u6709\u5173\u8d44\u6599\u6240\u5f15\u81f4\u7684\u9519\u8bef\u3001\u4e0d\u786e\u6216\u9057\u6f0f\uff0c\u6982\u4e0d\u8d1f\u4efb\u4f55\u6cd5\u5f8b\u8d23\u4efb\u3002<\/p>\n\n\n\n
\u672c\u7f51\u7ad9\u520a\u8f7d\u7684\u6240\u6709\u5185\u5bb9(\u5305\u62ec\u4f46\u4e0d\u4ec5\u9650\u6587\u5b57\u3001\u56fe\u7247\u3001LOGO\u3001\u97f3\u9891\u3001\u89c6\u9891\u3001\u8f6f\u4ef6\u3001\u7a0b\u5e8f\u7b49) \u7248\u6743\u5f52\u539f\u4f5c\u8005\u6240\u6709\u3002\u4efb\u4f55\u5355\u4f4d\u6216\u4e2a\u4eba\u8ba4\u4e3a\u672c\u7f51\u7ad9\u4e2d\u7684\u5185\u5bb9\u53ef\u80fd\u6d89\u5acc\u4fb5\u72af\u5176\u77e5\u8bc6\u4ea7\u6743\u6216\u5b58\u5728\u4e0d\u5b9e\u5185\u5bb9\u65f6\uff0c\u8bf7\u53ca\u65f6\u901a\u77e5\u672c\u7ad9\uff0c\u4e88\u4ee5\u5220\u9664\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
2024\u5e74\u5168\u56fd\u4e24\u4f1a\u53ec\u5f00\u671f\u95f4\uff0c\u7b2c\u5341\u56db\u5c4a\u5168\u56fd\u4eba\u5927\u4ee3\u8868\u3001\u9f50\u9c81\u5236\u836f\u603b\u88c1\u674e\u71d5\u51c6\u5907\u4e86\u591a\u4efd\u5efa\u8bae\u3002<\/p>\n","protected":false},"author":1,"featured_media":15898,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,31,13],"tags":[503],"class_list":["post-15896","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ceo","category-cxo","category-viewpoint","tag-503"],"_links":{"self":[{"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/posts\/15896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/comments?post=15896"}],"version-history":[{"count":1,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/posts\/15896\/revisions"}],"predecessor-version":[{"id":15902,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/posts\/15896\/revisions\/15902"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/media\/15898"}],"wp:attachment":[{"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/media?parent=15896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/categories?post=15896"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/cxounion.cn\/index.php\/wp-json\/wp\/v2\/tags?post=15896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

\u7ffb\u8bd1\uff1a<\/h2>\n\n\n\n